Tumor T-cell infiltration (CD4 + and CD8 + effector T cells) was observed in both xenogeneic cell and GC treatment and the combined therapy further increased T-cell population, which reflects effective immunotherapy. The gene discussed is CD8A; the disease is neoplasm.